Prognostic significance of High Mobility Group Box 1 (HMGB1) expression in patients with colorectal cancer

Anticancer Research

Volumn 34, Issue 10, 2014, Pages 5357-5362

  Ueda, Masami ^a,b   Takahashi, Yusuke ^b   Shinden, Yoshiaki ^a   Sakimura, Shotaro ^a   Hirata, Hidenari ^a   Uchi, Ryutaro ^a   Takano, Yuki ^a   Kurashige, Junji ^a   Iguchi, Tomohiro ^a   Eguchi, Hidetoshi ^a   Sugimachi, Keishi ^a   Yamamoto, Hirofumi ^b   Doki, Yuichiro ^b   Mori, Masaki ^b   Mimori, Koshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; HMGB1; Lymph node metastasis

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA;

AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERITONEUM METASTASIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; CANCER STAGING; COLORECTAL NEOPLASMS; GENE EXPRESSION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HMGB1 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RNA, MESSENGER;

EID: 84917692655     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bustin M, Lehn DA and Landsman D: Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1049: 231-243, 1990.
2. Scaffidi P, Misteli T and Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195, 2002.
3. Chen G, Li J, Ochani M, Rendon-Mitchell B, Qiang X, Susarla S, Ulloa L, Yang H, Fan S, Goyert SM, Wang P, Tracey KJ, Sama AE and Wang H: Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J Leukoc Biol 76: 994-1001, 2004.
4. Wang H, Vishnubhakat JM, Bloom O, Zhang M, Ombrellino M, Sama A and Tracey KJ: Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126 : 389-392, 1999.
5. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A and Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251, 1999.
6. Ostberg T, Kawane K, Nagata S, Yang H, Chavan S, Klevenvall L, Bianchi ME, Harris HE, Andersson U and Palmblad K: Protective targeting of high mobility group box chromosomal protein 1 in a spontaneous arthritis model. Arthritis Rheum 62: 2963-2972, 2010.
7. Park S, Yoon SJ, Tae HJ and Shim CY: RAGE and cardiovascular disease. Front Biosci (Landmark Ed) 16: 486-497, 2011.
8. Yang H and Tracey KJ: Targeting HMGB1 in inflammation. Biochim Biophys Acta 1799: 149-156, 2010.
9. Evankovich J, Cho SW, Zhang R, Cardinal J, Dhupar R, Zhang L, Klune JR, Zlotnicki J, Billiar T and Tsung A: High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem 285: 39888-39897, 2010.
10. Tang D, Kang R, Cao L, Zhang G, Yu Y, Xiao W, Wang H and Xiao X: A pilot study to detect high mobility group box 1 and heat shock protein 72 in cerebrospinal fluid of pediatric patients with meningitis. Crit Care Med 36 : 291-295, 2008.
11. Huang W, Tang Y and Li L: HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 51: 119-126, 2010.
12. Campana L, Bosurgi L and Rovere-Querini P: HMGB1: a twoheaded signal regulating tumor progression and immunity. Curr Opin Immunol 20: 518-523, 2008.
13. Chen J, Xi B, Zhao Y, Yu Y, Zhang J and Wang C: High-mobility group protein B1 (HMGB1) is a novel biomarker for human ovarian cancer. Gynecol Oncol 126 : 109-117, 2012.
14. Ellerman JE, Brown CK, de Vera M, Zeh HJ, Billiar T, Rubartelli A and Lotze MT: Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 13: 2836-2848, 2007.
15. Kang R, Zhang Q, Zeh HJ, 3rd, Lotze MT and Tang D: HMGB1 in cancer: good, bad, or both? Clin Cancer Res 19: 4046-4057, 2013.
16. Tang D, Kang R, Zeh HJ, 3rd and Lotze MT: High-mobility group box 1 and cancer. Biochim Biophys Acta 1799: 131-140, 2010.
17. Washington MK: Colorectal carcinoma: selected issues in pathologic examination and staging and determination of prognostic factors. Arch Pathol Lab Med 132 : 1600-1607, 2008.
18. Volp K, Brezniceanu ML, Bosser S, Brabletz T, Kirchner T, Gottel D, Joos S and Zornig M: Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 55: 234-242, 2006.
19. Xiang YY, Wang DY, Tanaka M, Suzuki M, Kiyokawa E, Igarashi H, Naito Y, Shen Q and Sugimura H: Expression of high-mobility group-1 mRNA in human gastrointestinal adenocarcinoma and corresponding non-cancerous mucosa. Int J Cancer 74: 1-6, 1997.
20. Lange SS and Vasquez KM: HMGB1: the jack-of-all-trades protein is a master DNA repair mechanic. Mol Carcinog 48: 571-580, 2009.
21. Travers AA: Priming the nucleosome: a role for HMGB proteins? EMBO Rep 4: 131-136, 2003.
22. Lotze MT and Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5 : 331-342, 2005.
23. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM and Schmidt AM: Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405 : 354-360, 2000.
24. Tang D, Kang R, Coyne CB, Zeh HJ and Lotze MT: PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 249 : 158-175, 2012.